Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
暂无分享,去创建一个
Ruzhu Chen | Aifeng Zhai | Xiao-nan Zhu | Xuelan Wang | Hai Wang | Hai Wang | Xuelan Wang | Aifeng Zhai | Xiaonan Zhu | Ruzhu Chen | Xiao‐nan Zhu
[1] P. Sonsalla,et al. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. , 1989, Molecular and chemical neuropathology.
[2] E. Hirsch,et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] I. Kurobane,et al. Cytostatic activity of naturally isolated isomers of secalonic acids and their chemically rearranged dimers. , 1987, Drugs under experimental and clinical research.
[4] W. Rausch,et al. Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells , 2004, Journal of Neural Transmission.
[5] Junying Yuan,et al. Apoptosis in the nervous system , 2000, Nature.
[6] Ruzhu Chen,et al. Secalonic acid A reduced colchicine cytotoxicity through suppression of JNK, p38 MAPKs and calcium influx , 2011, Neurochemistry International.
[7] L. Martin,et al. Neuronal cell death in nervous system development, disease, and injury (Review). , 2001, International journal of molecular medicine.
[8] W. Freed,et al. 5-Hydroxytryptamine 1A Receptor Activation Protects againstN-Methyl-d-aspartate-Induced Apoptotic Cell Death in Striatal and Mesencephalic Cultures , 2003, Journal of Pharmacology and Experimental Therapeutics.
[9] L S Freedman,et al. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. , 1978, Cancer research.
[10] H. Shiono,et al. Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture , 2003, Neuroscience Research.
[11] F. Hefti,et al. Toxicity of 1‐Methyl‐4‐Phenylpyridinium for Rat Dopaminergic Neurons in Culture: Selectivity and Irreversibility , 1990, Journal of neurochemistry.
[12] M. Karin,et al. Mitogen-activated protein kinase cascades and regulation of gene expression. , 1996, Current opinion in immunology.
[13] T. Dawson,et al. Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.
[14] L. Honig,et al. Apoptosis and neurologic disease. , 2000, The American journal of medicine.
[15] S. Kish,et al. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining , 1997, Neuroscience.
[16] P. Shaw,et al. Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP+, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells , 2012, Neuroscience Letters.
[17] M. Cobb,et al. Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.
[18] A. Kanthasamy,et al. Suppression of caspase-3-dependent proteolytic activation of protein kinase Cδ by small interfering RNA prevents MPP+-induced dopaminergic degeneration , 2004, Molecular and Cellular Neuroscience.
[19] Yizheng Wang,et al. Inhibition of glycogen synthase kinase-3β protects dopaminergic neurons from MPTP toxicity , 2007, Neuropharmacology.
[20] Todd B. Sherer,et al. An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.
[21] H. Lee,et al. Kynurenic acid attenuates MPP(+)-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway. , 2008, European journal of cell biology.
[22] K. Taylor,et al. Serotonergic activity of a novel tetrahydro-β-carboline , 1979 .
[23] N. Holbrook,et al. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. , 1998, The Biochemical journal.
[24] G. Gao,et al. Gypenosides protects dopaminergic neurons in primary culture against MPP+-induced oxidative injury , 2010, Brain Research Bulletin.
[25] F. Sun,et al. Melatonin protects against MPTP/MPP+‐induced mitochondrial DNA oxidative damage in vivo and in vitro , 2005, Journal of pineal research.
[26] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[27] C. Chu,et al. Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models. , 2009, Mitochondrion.
[28] J. Langston,et al. Pargyline prevents MPTP-induced parkinsonism in primates. , 1984, Science.
[29] Chang-Shin Park,et al. Leptin inhibits 1-methyl-4-phenylpyridinium-induced cell death in SH-SY5Y cells , 2006, Neuroscience Letters.
[30] D. Green,et al. Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death , 1999, Molecular and Cellular Biology.
[31] Mark J. West,et al. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias , 1999, Trends in Neurosciences.
[32] Gwang Lee,et al. A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP(+)-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling. , 2011, European journal of pharmacology.
[33] M. Quik,et al. Stimulation of non-α7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture , 2002, Neuroscience.
[34] M. Yamazaki,et al. Phlogistic activity of secalonic acid A. , 1974, Chemical & pharmaceutical bulletin.
[35] S. Przedborski,et al. Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.
[36] Jian-Jun Zhang,et al. The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells , 2007, Neuropharmacology.
[37] S. Amara,et al. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[39] H. Hatanaka,et al. Survival of and 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity against dopaminergic neurons in coculture of rat mesencephalon with their target or non-target regions , 1995, Neuroscience Research.
[40] S. Farooqui,et al. Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells. , 1994, Life sciences.
[41] J. Zimmer,et al. Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1‐methyl‐4‐phenylpyridinium in nigral slice cultures , 2003, Journal of neurochemistry.